Interest in diagnosis and treatment of pulmonary embolism (PE), a potentially fatal disease, is always high, especially among oncologic patients. In fact, not only tumors but also chemotherapy increases the risk to develop thromboembolic events in these particular patients. Moreover, nowadays, it frequently happens to detect incidental PE by imaging examinations performed for other purposes and, as oncologic patients are surely the ones who undergo the most of the diagnostic procedures, they are also the ones that more often are found to be affected by incidental, asymptomatic, pulmonary embolism.
Silvia Tresoldi, Nicola Flor and Andrea Luciani
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2018 All rights reserved. iMedPub LTD Last revised : November 18, 2018